Abstracts (HTML) List of Authors

Cai, Heng

Characterization of T cell subsets and dynamic remodeling following immune checkpoint inhibition in hepatocellular carcinoma

Calleja, Josune Cabello

Trends und Entwicklung des hepatozellulären Karzinoms durch ätiologische Verschiebung von 2005 bis 2020 in Deutschland: Bundesweite bevölkerungsbasierte Studie

Calvisi, Diego Francesco

Linker Phosphorylation of Smad3 as a Driver of Cholangiocarcinoma Progression and Chemotherapy Resistance

Cammann, Sebastian

Cytokine adsorption during normothermic machine perfusion of porcine livers

Canbay, Ali

30% with hepatic steatosis – but who is at risk? Defining Risk Factors for major liver-related Outcomes in patients with Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD)
Towards Establishing L-Ornithine-L-Aspartate as a Potential Basic Medication for Metabolic Dysfunction-associated Steatotic Liver Disease

Cantow, Chris

In vitro characterization of the drug metabolizing capacity of hepatocytes from MASH livers and development of a PK model for MASH patients

Cao, Feng

Machine Learning Highlights Association of Body Composition with Cholangiocarcinoma Mortality
Deep learning can predict PNPLA3 I148M homozygous carriers in SLD patients based on MRIs from UK Biobank
Impact of Diabetes and its management on MASLD risk

Carambia, Antonella

CRISPR/Cas9-mediated Cxcr3 gene knock-out in unstimulated murine primary CD4+T cells
Tolerance induction by liver sinusoidal endothelial cells is preserved in liver fibrosis

Carbone, Marco

Alkaline phosphatase and bilirubin as predictors of long-term outcomes in primary biliary cholangitis: A systematic literature review

Carrillo, Sebastian Lara

The role of sex-specific mitochondrial changes in the pathogenesis of fatty liver disease
Dynamics of disease progression and regeneration in a multiscale liver model

Casado, Mario Huerta

ROBO receptors function as tumor suppressors in cholangiocarcinoma

Castedello, Vivien Renée

Scherwellenelastografie übertrifft Fibroscan bei der Detektion von höhergradigen Ösophagusvarizen
Entwicklung eines klinischen Entscheidungsbaums für die nicht-invasive Diagnostik der Transplantat-Steatose bei Patienten nach Lebertransplantation

Castven, Darko

In-depth histological evaluation and comparison of mouse models for cholangiocarcinoma studies
Elevated uric acid levels are associated with an increased risk of fibrosis in MASLD

Cazzagon, Nora

Exploring the Role of Social Determinants of Health in autoimmune liver disease – a pilot study within the European Reference Network on hepatological diseases

Cervantes-Alvarez, Eduardo

Kurzfristige Mortalität und Diagnose von ACLF wird durch TIPS bei hydropischer Dekompensation aufgehoben: Eine Fall-Kontroll-Studie

Chaghaneh, Omid

Predicting Controlled Attenuation Parameter and Elastographic Modulus from Handheld Ultrasound Device Data using Machine Learning

Chakraborty, Anindita

Identification of amino acids restricting HBV receptor function in porcine NTCP

Chamulitrat, Walee

Myeloid- and hepatocyte-specific deletion of group VIA calcium-independent phospholipase A2 leads to opposing phenotypes during HFD-induced NASH

Chan, Stephen L.

Five-year overall survival (OS) and OS by tumour response measures from the Phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (uHCC)

Charlotte, Rohrer

Low risk of variceal bleeding in chronic non-cirrhotic portal vein thrombosis
Ultrasound and Elastography for Detection of Portal Hypertension in Common Variable Immunodeficiency

Chavarria, Tatiana

Mobile Ultrasound Screening Program for MASLD in High Cardiovascular Risk Communities in Rural Colombia: Initial Results

Chee, Grace

Improvement in liver histology is observed in most patients with chronic hepatitis delta after 48 weeks of bulevirtide monotherapy

Chen, Cheng

Stabilin1 mediates ingestion of oxidized erythrocytes by LSECs (efferocytosis)

Chen, Fuwang

Generation and functional analysis of spacer-modified HBV-specific chimeric antigen receptors

Chen, Jiadao

Generation and functional analysis of spacer-modified HBV-specific chimeric antigen receptors

Chen, Xinlai

Linker Phosphorylation of Smad3 as a Driver of Cholangiocarcinoma Progression and Chemotherapy Resistance

Chen, Yazhou

Machine Learning Highlights Association of Body Composition with Cholangiocarcinoma Mortality
Deep learning can predict PNPLA3 I148M homozygous carriers in SLD patients based on MRIs from UK Biobank
Machine learning identifies microbiome associations with MASLD biomarkers
Impact of Diabetes and its management on MASLD risk

Cheng, Cho-Chin

Spontaneous HCC development in mice expressing all HBV transcripts is STAT3 dependent and indicates an oncogenic effect of HBx

Choi, Yun-Jung

Baseline Characteristics and Risk Profiles of 1111 Patients With Primary Biliary Cholangitis (PBC) in Need of Second-Line Therapy

Chorostowska-Wynimko, Joanna

Interaktion zwischen metabolischen Faktoren und Genetik am Beispiel Alpha-1-Antitrypsin-Mangel

Chung, Brian

Distinct gene pathways and cell types define peribiliary disease states in PSC

Ciesek, Sandra

Improvement in liver histology is observed in most patients with chronic hepatitis delta after 48 weeks of bulevirtide monotherapy

Claria, Joan

Kurzfristige Mortalität und Diagnose von ACLF wird durch TIPS bei hydropischer Dekompensation aufgehoben: Eine Fall-Kontroll-Studie

Clark, Andrew R.

Disrupting the intracellular MK2/3-TTP interaction reduces inflammation but preserves antiviral mechanisms in CMV infection

Clark, Virginia

Interaktion zwischen metabolischen Faktoren und Genetik am Beispiel Alpha-1-Antitrypsin-Mangel

Claussnitzer, Melina

Association of the PNPLA3 p.I148M common variant with increased resting energy expenditure in the context of cold adaptation in humans

Clermont, Christian

Elevated uric acid levels are associated with an increased risk of fibrosis in MASLD

Clusmann, Jan

Multimodal characterization of autoimmune hepatitis morbidity and metabolic phenotype
30% with hepatic steatosis – but who is at risk? Defining Risk Factors for major liver-related Outcomes in patients with Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD)
Deep learning can predict PNPLA3 I148M homozygous carriers in SLD patients based on MRIs from UK Biobank

Cobitz, Alexander

Insufficient control of cholestatic pruritus in primary biliary cholangitis (PBC) with current therapies: baseline data from the ongoing Phase 3 GLISTEN (Global Linerixibat Itch STudy of Efficacy and safety iN PBC) trial

Cohen, Yotam

Antibiotic-mediated microbiota depletion limits IgA-related fibrogenesis in metabolic dysfunction-associated steatohepatitis

Collardeau-Frachon, Sophie

Unique histological liver phenotype in children and adults with severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype)

Conrad, Marcus

The ferroptosis mediator ACSL4 fails to prevent disease progression in mouse models of MASLD

Conradi, Anna Maria

Unterschiedliche Cluster des intestinalen Mikrobioms bei fortgeschrittener Leberzirrhose korrelieren mit Antibiotikabehandlung, Störungen der Darmbarriere und systemischer Inflammation

Cooper, Lucy

Myeloid reprogramming of T cells: a mechanism to maintain peritoneal homeostasis

Cornberg, Markus

Previous hepatitis B virus infection and the risk of liver-related complications in patients after HCV cure – Data on more than 6000 patients from the German Hepatitis C-Registry (DHC-R)
Improvement in liver histology is observed in most patients with chronic hepatitis delta after 48 weeks of bulevirtide monotherapy
Granzyme profiles in CXCR6+PD-1+CD8+T cells differentiate acute and chronic hepatitis flares and may reflect intrahepatic immune imprints
Circulating CD8 T cells are sentinels for intrahepatic T cell responses during HBV infection
Immune activation as a hallmark in liver disease progression
Cytotoxic CD16+γδ T Cells Are Associated with Virus Control in Chronic Hepatitis B Virus (HBV) Infection by Mediating Antibody-Dependent Cellular Cytotoxicity (ADCC)
Unterschiedliche Cluster des intestinalen Mikrobioms bei fortgeschrittener Leberzirrhose korrelieren mit Antibiotikabehandlung, Störungen der Darmbarriere und systemischer Inflammation
Myeloid reprogramming of T cells: a mechanism to maintain peritoneal homeostasis
Non-Selective Beta Blockers Reduce Inflammatory Bystander CD8+T Cell Activation in Decompensated Cirrhosis

Corradini, Stefanie

Circulating tumor cells predict recurrence risk in early HCC treated with local ablative therapy
MR guided catheter-based radiotherapy/brachytherapy of liver tumours – first experience and feasibility
Single Shot Liver: MR-guided stereotactic body radiotherapy (SBRT) for hepatic malignancies and metastasis

Cortellini, Alessio

Characterization of T cell subsets and dynamic remodeling following immune checkpoint inhibition in hepatocellular carcinoma

Costa, Ivan G.

Deep learning can predict PNPLA3 I148M homozygous carriers in SLD patients based on MRIs from UK Biobank

Cristoferi, Laura

Safety and efficacy of Upadacitinib in patients with primary sclerosing cholangitis: a multicentre, retrospective study

Crittenden, Daria B.

Baseline Characteristics and Risk Profiles of 1111 Patients With Primary Biliary Cholangitis (PBC) in Need of Second-Line Therapy
Efficacy and Safety of Seladelpar in Patients With Primary Biliary Cholangitis and Compensated Liver Cirrhosis in the Open-Label, Long-Term ASSURE Safety Study: Interim Results

Crysler, Oxana

Five-year overall survival (OS) and OS by tumour response measures from the Phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (uHCC)

Culver, Emma

Safety and efficacy of Upadacitinib in patients with primary sclerosing cholangitis: a multicentre, retrospective study

Currie, Brooke

Clinically significant itch on the PBC-40 corresponds to moderate-severe itch on the worst itch numerical rating scale (NRS) in patients with pruritus and primary biliary cholangitis (PBC)
Insufficient control of cholestatic pruritus in primary biliary cholangitis (PBC) with current therapies: baseline data from the ongoing Phase 3 GLISTEN (Global Linerixibat Itch STudy of Efficacy and safety iN PBC) trial

Cutts, Katelyn

Clinically significant itch on the PBC-40 corresponds to moderate-severe itch on the worst itch numerical rating scale (NRS) in patients with pruritus and primary biliary cholangitis (PBC)